Skip to content
healthcare.dev

CHOLESTYRAMINE

NDC 42806-267, cholestyramine, powder, for suspension, from EPIC PHARMA, LLC.

Product NDC
42806-267
Status
Listed
Labeler
EPIC PHARMA, LLC
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA074557
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42806-267 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CHOLESTYRAMINE4 g/9g

Pharmacologic classes

Bile Acid Sequestrant [EPC]; Bile-acid Binding Activity [MoA]

Package NDCNDC-11Package
42806-267-9342806026793378 g in 1 JAR (42806-267-93)
42806-267-9742806026797378 g in 1 CAN (42806-267-97)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c65e556a-3b6a-4466-a7ce-5b24103ed8ad
  • NADAC price for package 42806026793

    GET /v1/drugs/nadac/42806026793

Use it

Look up 42806-267 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42806-267 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42806-267. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.